Azurity-Solutions The ONLY liquid formulations of these molecules you know and trust: topiramate and zonisamide

Medication
Transformed

Please note that ZONISADETM (zonisamide oral suspension) 100 mg/5 mL and EPRONTIATM (topiramate) oral solution, 25 mg/mL are two different pharmaceutical products. ZONISADETM cannot be used as adjunctive therapy with EPRONTIATM or other forms of topiramate.

The ONE and ONLY ready-to-use liquid topiramate

Learn More

The ONE and ONLY ready-to-use* liquid zonisamide
*Shake well before administering.

Learn More

EPRONTIATM (topiramate) oral solution, 25 mg/mL

Indications

  • Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.
  • Adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older.
  • Preventive treatment of migraine in patients 12 years of age and older.

Inform patients that a calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device.

ZONISADETM (zonisamide oral suspension), 100 mg/5 mL

ZONISADE is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older.

Inform patients that a calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device.

From Azurity Pharmaceuticals

An industry leader with a 10-year legacy of developing FDA-approved liquid formulations of established medicines.

Actor portrayal

Introducing the Azurity CNS Portfolio

Innovative products that address the specific needs of overlooked patient segments and meet increasing demands of healthcare providers

A growing portfolio of products designed to provide unique, accessible, and high-quality medications to patients

Provides alternative options for patients who prefer oral liquid formulations or who may have difficulty swallowing pills or capsules